Original articlesPrecision medicineMolecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial
Precision medicine
Under an Elsevier user license
open archive
Key words
advanced cancer
molecular profiling
precision medicine
molecular-targeted agents
decision-making
Cited by (0)
Copyright © 2019 THE AUTHORS. Published by Elsevier Ltd. All rights reserved.